1. Introduction {#sec1}
===============

Kidney calculi is a common urological disorder which is characterized by high recurrence rate \[[@B1]\]. The stone movement leading to renal colic and the obstruction by calculi could result in kidney function loss. Recently, the incidence of kidney calculi has been on the rise in China, probably caused by the changed climate and environment. For releasing the obstruction, urologists choose different treatments for different size calculi diameter from less than 0.6 cm to more than 3.0 cm. As the guidelines recommend, percutaneous nephrolithotomy (PCNL), of which standard access tracts are 24--30 French (Fr), is a recommended management of patients with renal or ureteral stones more than 20 mm or and for smaller stones (10--20 mm) of the lower pole stones when anatomic factors make extracorporeal shockwave lithotripsy (ESWL) unfavorable. Although PCNL is suggested as a standard method for its excellent stone-free rate, there is still few surgical drawbacks that may compromise its efficacy \[[@B1]\].

For reducing postoperative morbidity associated with large devices such as blood loss, fever, and potential renal damage, minimally invasive tract has been applied widely. Minimally invasive PCNL (also termed mini-PCNL or mini-Perc or mPCNL), a miniature endoscope via a small percutaneous tract (11--20 Fr), is widely executed in the recent years \[[@B2], [@B3]\]. Mini-PCNL was described by Helal et al. Firstly performed on a 2-year-old child by the use of instruments with smaller access diameters in 1997 and developed by Jackman et al. to be a therapy option for adults \[[@B4], [@B5]\] compared to the standard tract PCNL, mini-PCNL has a more gracile tract of \<20 Fr, which leads to less nephron loss and other postoperative complications; meanwhile the stone-free rate seems to have no significant difference \[[@B6], [@B7]\].

On the other hand, retrograde intrarenal surgery (RIRS) (also termed flexible ureterorenoscopy, F-URS), is another major minimally invasive measure for managing the upper urinary calculi. For its characteristics of little trauma, quick recovery, easy operation, and little contraindication, RIRS has been considered as an alternative for the percutaneous approaches for lower pole stones treatment \[[@B8], [@B9]\]. RIRS is a safe procedure with lower complication rates, blood loss, shorter length of stay, and lower stone-free rate than PCNL \[[@B10]\].

Mini-PCNL and RIRS are two effective minimally invasive approaches to release the obstruction. For the question of which one should be the better choice to replace the standard tract PCNL, there is not yet enough high-quality data to provide evidence. Therefore, we conducted this systematic review and meta-analysis of available literatures comparing SFR and other surgery-related parameters of mini-PCNL to RIRS for the treatment of kidney calculi.

2. Materials and Methods {#sec2}
========================

2.1. Studies Selection {#sec2.1}
----------------------

This meta-analysis was performed in September 2016 using PubMed, Cochrane Library, Embase, and Web of Science databases to identify related studies in accordance with the meta-analysis (PRISMA) guidelines (<http://www.prismastatement.org>) and preferred reporting items for a systematic review. Search strategy was as follows: (kidney stone OR urolithiasis OR kidney calculus OR kidney calculi OR renal stone OR nephrolith OR renal calculus) AND (mini-PCNL OR mPCNL OR minimally invasive surgery OR minimally invasive percutaneous nephrolithotomy OR minipercutaneous OR miniaturized PCNL OR ultra-mini-PCNL) AND (retrograde intrarenal surgery OR RIRS OR flexible ureteroscopy OR flexible ureterorenoscopy OR retrograde ureterolithotripsy).

Before the study search, we circumscribed inclusion criteria including (1) patients with kidney calculi, (2) the age \>18, (3) comparing mini-PCNL with RIRS, (4) reporting at least one of the following outcomes (operative time, SFR, hemoglobin drop, hospitalization time, or postoperative complications), and (5) related parameters that could be obtained from the studies. And exclusion criteria were as follows: (1) nephrostomy tract size in mini-PCNL \>20 F or \<11 F; (2) conference abstracts which were not deemed to be methodologically appropriate; (3) non-English papers; (4) the inclusion criteria that were not met. Two authors accomplished the review process independently. A third author arbitrated disagreements in data extraction by consensus.

2.2. Data Quality Assessment {#sec2.2}
----------------------------

As shown in [Table 1](#tab1){ref-type="table"}, we rated the level of evidence (LE) of every included trail according to the Oxford Centre for Evidence-Based Medicine Criteria \[[@B11]\]. The qualities of nonrandomized controlled trials (non-RCTs) were assessed according to Newcastle-Ottawa Scale (NOS), and RCTs qualities were assessed by the Jadad scale \[[@B12], [@B13]\]. Two reviewers performed the procedure independently and all disagreements were resolved by consensus.

2.3. Data Extraction and Statistical Analysis {#sec2.3}
---------------------------------------------

All meta-analyses were performed to assess the overall outcomes using Review Manager Software (RevMan v.5.3, Cochrane Collaboration, Oxford, UK). Extracted data for the analysis included stone-free rate, operative time, hemoglobin drop, length of hospital stay, and postoperative complication rate. If standard deviations were not reported we estimated data according to Hozo SP \[[@B14]\], and if standard deviation (SD) could not be calculated from available data, we asked authors to supply the data. For evaluating dichotomous variables, we chose odds ratio (OR), and, for continuous parameters, weighted mean difference (WMD) or standardized mean difference was used. The Cochrane chi-square test and inconsistency (*I*^2^) were used to evaluate the heterogeneity among studies. Pooled estimates were calculated with the fixed-effect model for stone-free rate, and the other outcomes were calculated with the random-effect model due to the heterogeneity. Funnel plots were generated using RevMan v.5.3 to evaluate published bias of literatures. In addition, we included high-quality studies (RCTs and high score non-RCTs (NOS: 7 of 9 points)) into meta-analysis for sensitive analysis.

3. Results {#sec3}
==========

3.1. Study Characteristics and Quality {#sec3.1}
--------------------------------------

Thirteen trails were selected for analysis including a total of 701 mini-PCNL cases (53.2%) and 616 RIRS cases (46.8%) in our meta-analysis. The literature screening process is shown in [Figure 1](#fig1){ref-type="fig"}.

The baseline characteristics of the included studies are shown in Tables [2](#tab2){ref-type="table"} and [3](#tab3){ref-type="table"}. Surgical technique for mini-PCNL differed in aspect of tract size and lithotripsy. As shown in [Table 1](#tab1){ref-type="table"}, the studies consisted of three RCTs (LE: 2b) \[[@B17], [@B16], [@B15]\], two matched-pair analysis trails (LE: 3b) \[[@B18], [@B19]\], and eight case control studies (LE: 3b) including 4 prospective \[[@B22], [@B21], [@B23], [@B20]\] and 4 retrospective studies \[[@B27], [@B24], [@B25], [@B26]\]. In terms of the methodological quality, eight and two of the nonrandomized studies were relatively high (NOS: 7 of 9 points and 6 of 9 points) and medium (NOS: 5 of 9 points and 4 of 9 points), respectively. The three RCTs were of medium quality (Jadad scale: 3 of 5 points). In 3 studies, mini-PCNL and RIRS were compared between patients with a single stone. There were also two studies comparing mini-PCNL with RIRS for proximal ureteral stones, whereas the rest were compared for renal calculi. In general, the preoperative demographic characteristics such as mean age (51.80 ± 14.80 versus 49.9 ± 14.29 year) were comparable between mini-PCNL and RIRS.

4. The Results of Parameters in Meta-Analysis {#sec4}
=============================================

4.1. Stone-Free Rate (SFR) {#sec4.1}
--------------------------

SFR was evaluated with fixed-effect model, and the comparison of stone-free rate between the mini-PCNL and RIRS group is shown in [Figure 2](#fig2){ref-type="fig"}. All involved studies reported postoperative stone-free rate, and the result suggested that mini-PCNL group provided a significantly higher SFR than RIRS group (OR: 1.96; 95% CI, 1.46--2.64; *P* \< 0.00001) with no significant homogeneity (*I*^2^ = 42%). As the stone location subgroup meta-analysis shows ([Figure 3](#fig3){ref-type="fig"}), mini-PCNL has significantly higher SFR than RIRS in any location (OR: 2.13; 95% CI, 1.53--2.96; *P* \< 0.00001). [Figure 4](#fig4){ref-type="fig"} shows that mini-PCNL can lead to higher stone clearance in both 1-2 cm (OR: 2.01; 95% CI, 1.27--3.19; *P* = 0.003) and \>2 cm subgroups (OR: 2.65; 95% CI, 1.81--3.87; *P* \< 0.0001).

4.2. Operative Time {#sec4.2}
-------------------

Twelve studies combined had reported operative time, which was evaluated with random effect model. As the meta-analysis result shows in [Figure 5(a)](#fig5){ref-type="fig"}, there was no remarkable difference between mini-PCNL and RIRS (WMD, −2.21; 95% CI, −12.62--8.20; *P* = 0.68).

4.3. Hospital Stay {#sec4.3}
------------------

In 10 studies there were available data to extract in terms of hospital stay, which was analyzed by random effect model. As shown in [Figure 5(b)](#fig5){ref-type="fig"}, hospital stay for RIRS is shorter than mini-PCNL (WMD: 1.63 d; 95% CI, 0.98--2.28; *P* \< 0.00001).

4.4. Hemoglobin (Hb) Drop {#sec4.4}
-------------------------

Hb drop was analyzed by random effect model, and the result was shown in [Figure 5(c)](#fig5){ref-type="fig"}. Six studies provided accessible data about Hb drop and the meta-analysis shows that RIRS led to less Hb drop than mini-PCNL (WMD, 0.60; 95% CI, 0.32--0.88; *P* \< 0.0001).

4.5. Complication Rate {#sec4.5}
----------------------

All studies reported available data for the assessment of the complications between mini-PCNL and RIRS group. Random effect model and OR were used for statistical analysis and the result is shown in [Figure 6](#fig6){ref-type="fig"}. RIRS has a lower complication rate than mini-PCNL (OR: 1.62; 95% CI, 0.92--2.88; *P* = 0.10). Furthermore, we analyzed the complications according to Clavien-Dindo Classification ([Table 4](#tab4){ref-type="table"}) to evaluate minor indisposition and major complication \[[@B28], [@B29]\]. As the results show, there is no significant difference between grade I and grade III complications between the two groups (OR: 1.24, 95% CI, 0.66--2.32, *P* = 0.51; OR: 1.41, 95% CI, 0.97--2.04, *P* = 0.77); however, we observed a significantly lower incidence of grade II complications in RIRS group (OR: 1.63; 95% CI, 1.01--2.63; *P* = 0.04) ([Figure 7](#fig7){ref-type="fig"}).

4.6. Sensitivity Analysis {#sec4.6}
-------------------------

The sensitivity analysis suggested that the results of this meta-analysis were relatively stable ([Table 5](#tab5){ref-type="table"}). When only RCTs and high score non-RCTs (NOS: 7 of 9 points) were included, most of the outcomes including stone-free rate, operative time, total postoperative complications, and grade I and III surgery complications were not greatly changed. Meanwhile, significant differences of grade II complications, hemoglobin drop, and hospital stay between two groups were not found because of the reduced sample capacity. It is notable that even if the significant differences were no longer detectable in the sensitivity analysis, the tendency of meta-analysis stayed in the same direction.

4.7. Publish Bias Analysis {#sec4.7}
--------------------------

The funnel plot ([Figure 8](#fig8){ref-type="fig"}) showed an apparent asymmetry, which suggested the existence of a potential publication bias.

5. Discussion {#sec5}
=============

With high technological advancement, urologists who take charge of urolithiasis are in possession of high technique instruments, which leads to safer and more effective lithotripsy. So far PCNL is considered to be the recommended therapy for large stones \> 2.0 cm by both AUA and EAU guidelines. Furthermore, with the development of the "mini-PCNL" procedure, smaller access sheaths (≤20 F) are becoming increasingly popular for its relative safety. Besides, recent reports suggested that RIRS is a safer approach that could lead to less complications and Hb drop than normal tract PCNL. We conducted this meta-analysis to systematically analyze the outcomes of two miniature procedures, mini-PCNL and RIRS, which cause considerably lesser trauma than standard PCNL, to find which one could lead to better efficacy and safety. And, to the best of our knowledge, this meta-analysis is an update analysis comparing these two modern minimally invasive approaches applying for upper urinary stone.

SFR is the most important parameter for estimating the efficacy of two approaches. According to the synthesis analysis of data, mini-PCNL has a higher SFR than RIRS group though there were various imaging modalities to identify. Stone-free rates are correlated with the lithotripsy and the location or size of stones. Seven inclusive studies used only laser to dispose stones and others made use of pneumatic or ultrasound waves to fragment calculi. Zhang et al. and Gu et al. included only proximal ureter stones and almost all included trails studied stones \>10 mm. To evaluate the different locations that may impact SFR of two procedures, a subgroup analysis was performed. As [Figure 3](#fig3){ref-type="fig"} shows, the proximal and low pole subgroups did not show any remarkable advantage of two approaches, while all locations showed that mini-PCNL has a significant advantage in SFR. Additionally, one stone size subgroup analysis was performed to estimate the impact on meta-analysis; results showed that mini-PCNL has more efficiency stone clearance in both 1-2 cm and \>2 cm groups ([Figure 4](#fig4){ref-type="fig"}). Besides, mini-PCNL carries high efficiency quotient (EQ) ([Table 6](#tab6){ref-type="table"}), which was related to SFR, percentage retreatment, and percentage requiring an auxiliary procedure (as the following formula) \[[@B30], [@B31]\], reported by three included studies ([Table 5](#tab5){ref-type="table"}) \[[@B22], [@B16], [@B15]\]. However, De et al. had performed a meta-analysis that compared PCNL and RIRS for managing kidney stone and the results showed that RIRS can provide higher stone-free rates compared with mPCNL, which was opposite to our results \[[@B10]\]. It should be noted that only 5 literatures were included in the previous study, and the "mPCNL" in this study referred to micronephroscope which is 4.85 Fr and mini-PCNL from 11 to 19 Fr. This diversity of definition and sample size may result in the outcomes\' difference between our meta-analysis and the previous study. Including more relative studies, the outcome would become more reliable. $$\begin{matrix}
{{EQ}^{31} = \frac{precentage\,\, of\,\, stone\text{-}free}{100 + precentage\,\, of\,\, retreatment + precentage\,\, of\,\, auxiliary\,\, procedure}} \\
\end{matrix}$$Operative times were reported in 12 involved studies, and six studies indicated that mini-PCNL spent shorter operating time, while four studies favored RIRS. The overall meta-analysis showed that two procedures brought no significantly varied operation time; meanwhile, we noticed the heterogeneity in this section was as high as 97%, mainly led by Kumar et al., Gu et al., Ozgor et al., and Wilhelm et al. \[[@B27], [@B18], [@B16], [@B15]\]. If the four studies were excluded, heterogeneities would be declined to 70%, and the preference would favor mini-PCNL procedure. Operative time is closely related to nuance in surgical techniques and doctors\' experience, different surgeons in different centers provided a large variation in operative time, and a significant heterogeneity was proved from twelve inclusive studies.

The overall analysis found that RIRS resulted in shorter hospital stay than mini-PCNL group. The reason for this difference might be less invasive caused by RIRS. Moreover, it carries lower complication rate and hemoglobin drop.

The size of the tract is one key factor for blood loss during endourology surgery, so mini-PCNL with miniature tract can reduce bleeding and the risk of blood transfusion compared to normal tract PCNL \[[@B32]\]. Besides, the overall analysis of the literature suggested that RIRS resulted in less hemoglobin drop than mini-PCNL. Accordingly, RIRS has a high efficiency for the management of intrarenal stones with a slight complication to patients \[[@B33], [@B34]\].

All trails have made the comparison of postoperative morbidity between mini-PCNL and RIRS. The results showed that RIRS provided a lower complication rate than mini-PCNL; however, the difference had no significance. The complications of mini-PCNL are similar to those of PCNL; bleeding, pain, and fever are very common \[[@B35]--[@B38]\].

Furthermore, we performed a subgroup meta-analysis of postoperative complications, classifying them into grades I, II, and III based on Clavien-Dindo Classification, between the two groups \[[@B28]\]. As [Table 4](#tab4){ref-type="table"} shows, grade I represents the morbidities that needed no pharmacological or surgical treatment, which could easily occur after operation, and grade III means complications requiring surgical, endoscopic, or radiological intervention, which rarely occur after lithotripsy operation. Thus, we did not observe a remarkable difference in comparison of grade I. Grade III complications were only observed in 5 studies, and the result showed that RIRS has a potential safety on severe complications. As for grade II complications, mini-PCNL has a significantly higher rate than RIRS according to our meta-analysis, which means RIRS was probably safer with respect to middle or severe morbidities after operation, and, in term of light deviations, the incidences of mini-PCNL and RIRS were similar.

There are several limitations in the present meta-analysis. In our systematic review and meta-analysis, we included the currently available comparative studies. Although we have done the sensitivity analysis to show that the results were relatively stable, there is still some bias of our conclusion caused by non-RCTs. Besides, heterogeneities among involved literatures, which may relate to diverse calculi size and location, different tract size, and lithotripsies, could lead to some limitations in our meta-analysis. In addition, most of the included trials failed to describe complications with the same criteria and blinding procedures in detail, and this might lead to conclusion bias, as the more details the literatures describe, the more credible the conclusion will be concluded. However, to the best of our knowledge, this study is one update review and meta-analysis to compare mini-PCNL and RIRS for treating renal calculi. We believe the results of the present meta-analysis could help urologists make better clinical decisions to manage stone disease patients.

6. Conclusions {#sec6}
==============

From this meta-analysis, we found that both mini-PCNL and RIRS can provide safe and effective treatment for renal calculi patients. In the light of these results, compared with RIRS, mini-PCNL provided significantly higher stone-free rate and efficiency quotient for management of upper urinary calculi, however, could increase the incidence of postoperative complications and the average hospital stay.
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###### 

Summary of included studies.

  Study                       Institution (country)                                                   Study period   Study design                 LE   Inclusion criteria                                 Cases, *n*   Study quality   
  --------------------------- ----------------------------------------------------------------------- -------------- ---------------------------- ---- ------------------------------------------------- ------------- --------------- --------
                                                                                                                                                                                                         mPCNL         RIRS             
  Lee et al. \[[@B17]\]       Dongguk University Ilsan Hospital (South Korea)                         2014-2015      RCT                          2b   \>1 cm, single or multiple renal stones           35            33              3^*∗*^
  Ozgor et al. \[[@B27]\]     Haseki Teaching and Research Hospital (Turkey)                          2012--2015     Retrospective case control   3b   1-2 cm, BMI \> 30 kg/m^2^, any location           56            56              7^\#^
  Wilhelm et al. \[[@B18]\]   University Medical Centre Freiburg (Germany)                            2013-2014      Matched-pair analysis        3b   1--3.5 cm                                         25            25              5^\#^
  Pan et al. \[[@B22]\]       Renji Hospital (China)                                                  2005--2011     Prospective case control     3b   2-3 cm, single stone, any location                59            56              6^\#^
  Kirac et al. \[[@B24]\]     Koru Hospital (Turkey)                                                  2009--2012     Retrospective case control   3b   \<1.5 cm, lower pole                              37            36              6^\#^
  Kumar et al. \[[@B16]\]     V.M. Medical College and Safdarjung Hospital (India)                    2012-2013      RCT                          2b   1-2 cm, single stone, lower pole                  41            43              3^*∗*^
  Sabnis et al. \[[@B21]\]    Muljibhai Patel Urological Hospital (India)                             2009--2011     Prospective case control     3b   1-2 cm, single or multiple stones, any location   32            32              6^\#^
  Kruck et al. \[[@B25]\]     Multiple institutions (Germany)                                         2001--2007     Retrospective case control   3b   Any size, any location                            172           108             4^\#^
  Hu et al. \[[@B26]\]        Tongji Hospital (China)                                                 2010--2015     Retrospective case control   3b   1-2 cm, any location, older than 60 years old     104           80              6^\#^
  Zeng et al. \[[@B19]\]      The First Affiliated Hospital of Guangzhou Medical University (China)   2012--2014     Matched-pair analysis        3b   \>2 cm, any location, solitary kidney             53            53              7^\#^
  Zhang et al. \[[@B23]\]     Wu Jieping Urology Center (China)                                       2010--2012     Prospective case control     3b   1-2 cm, single stone, proximal ureter             32            44              6^\#^
  Gu et al. \[[@B15]\]        Jiangsu Province Hospital (China)                                       2010-2011      RCT                          2b   ≥1.5 cm, proximal ureter                          30            29              3^*∗*^
  Knoll et al. \[[@B20]\]     Klinikum Sindelfingen-Boeblingen Medical Center (Germany)               2008--2010     Prospective case control     3b   1--3 cm, solitary renal calculi, any location     25            21              6^\#^

LE = level of evidence; mPCNL = minimally invasive PCNL; RIRS = retrograde intrarenal surgery, RCT = randomized controlled trials.

^\#^Using Newcastle--Ottawa Scale (score from 0 to 9).

^*∗*^Using Jadad scale (score from 0 to 5).

###### 

Characters of patients and calculus.

  Study                       Treatment        Age (year)       Male/Female           BMI (kg/m^2^)          Stone size (mm)        Stone location (%)                               
  --------------------------- ---------------- ---------------- --------------------- ---------------------- ---------------------- -------------------- ------ ------ ------ ------ ------
  Lee et al. \[[@B17]\]       Mini-PCNL        59.3 ± 13.3      28/7                  26.3 ± 3.9             39.1 ± 30.7            2.9                  ---    40.0   17.1   ---    40.0
  RIRS                        55.8 ± 11.2      28/5             25.6 ± 5.1            28.9 ± 17.5            3.0                    ---                  30.3   27.3   ---    39.4   
  Ozgor et al. \[[@B27]\]     Mini-PCNL        51.4 ± 14.3      25/31                 34.0 ± 3.3             19.5 ± 3.9             8.9                  1.8    26.8   25.0   ---    37.5
  RIRS                        54.2 ± 10.6      22/34            34.4 ± 5.0            18.3 ± 3.2             7.1                    1.8                  26.8   39.3   ---    25.0   
  Wilhelm et al. \[[@B18]\]   Mini-PCNL        51.56 (15--75)   15/10                 29.54 (18.75--42.94)   19.3 (10--35)          ---                  ---    ---    ---    ---    ---
  RIRS                        51.36 (19--77)   19/6             28.41 (18.4--38.57)   19.2 (10--35)          ---                    ---                  ---    ---    ---    ---    
  Pan et al. \[[@B22]\]       Mini-PCNL        49.37 ± 14.2     37/22                 23.52 ± 3.7            22.37 ± 2.7            8.5                  18.6   52.5   20.3   ---    ---
  RIRS                        49.32 ± 13.7     36/20            23.69 ± 3.6           22.28 ± 2.6            12.5                   12.5                 51.8   23.2   ---    ---    
  Kirac et al. \[[@B24]\]     Mini-PCNL        41.02 ± 10.3     25/12                 18.5 ± 4.9             10.5 ± 2.2             ---                  ---    100    ---    ---    ---
  RIRS                        37.8 ± 8.7       22/14            18.3 ± 5.0            10.2 ± 2.9             ---                    ---                  100    ---    ---    ---    
  Kumar et al. \[[@B16]\]     Mini-PCNL        33.7 ± 1.6       20/21                 23.5 ± 1.2             13.3 ± 1.3             ---                  ---    ---    ---    ---    ---
  RIRS                        33.4 ± 1.4       20/23            23.6 ± 1.1            13.1 ± 1.1             ---                    ---                  ---    ---    ---    ---    
  Sabnis et al. \[[@B21]\]    Mini-PCNL        44.48 ± 12.36    19/13                 ---                    15.2 ± 3.3             3.1                  0.0    31.3   43.8   ---    21.9
  RIRS                        49.28 ± 12.19    25/7             ---                   14.2 ± 3.4             9.4                    3.1                  28.1   25.0   ---    34.4   
  Kruck et al. \[[@B25]\]     Mini-PCNL        53.3 ± 14.8      109/63                ---                    12.6 ± 9.5             ---                  ---    42.7   ---    ---    ---
  RIRS                        50 ± 16.7        69/39            ---                   6.8 ± 6.9              ---                    ---                  76.8   ---    ---    ---    
  Hu et al. \[[@B26]\]        Mini-PCNL        65.5 ± 4.9       56/48                 23.7 ± 3.5             15.8 ± 3.4             1.9                  7.7    13.5   40.4   36.5   59.6
  RIRS                        65.1 ± 5.2       45/35            23.0 ± 3.1            15.8 ± 3.4             3.8                    12.5                 17.5   37.5   28.8   57.5   
  Zeng et al. \[[@B19]\]      Mini-PCNL        53.04 ± 14.09    36/17                 23.26 ± 3.41           329.34 ± 184.27^*∗*^   3.8                  3.8    22.6   22.6   ---    47.2
  RIRS                        48.47 ± 11.96    39/14            23.63 ± 3.83          331.87 ± 182.55^*∗*^   5.7                    3.8                  18.9   26.4   ---    45.3   
  Zhang et al. \[[@B23]\]     Mini-PCNL        42.7 ± 13.6      24/8                  ---                    15.6 ± 2.5             ---                  ---    ---    ---    100    ---
  RIRS                        43.3 ± 11        29/15            ---                   14.9 ± 2.3             ---                    ---                  ---    ---    100    ---    
  Gu et al. \[[@B15]\]        Mini-PCNL        42.5 ± 10.1      ---                   ---                    17.27 (15--25)         ---                  ---    ---    ---    100    ---
  RIRS                        44.22 ± 13       ---              ---                   16.23 (15--25)         ---                    ---                  ---    ---    100    ---    
  Knoll et al. \[[@B20]\]     Mini-PCNL        56 ± 13          15/10                 27 ± 5                 18 ± 5                 4.0                  68.0   12.0   56.0   ---    ---
  RIRS                        53 ± 11          9/12             31 ± 7                19 ± 4                 9.5                    66.7                 4.8    38.1   ---    ---    

*Note.* Mini-PCNL = minimally invasive percutaneous nephrolithotomy; RIRS = retrograde intrarenal surgery; Unit = mm^2^; all other units are in millimeters.

###### 

The characters of the surgical methods of included studies.

  Study                       Treatment           Access sheath size, Fr   Dilator                  Nephroscope size          Lithotripsy
  --------------------------- ------------------- ------------------------ ------------------------ ------------------------- --------------------------------
  Lee et al. \[[@B17]\]       Mini-PCNL           18                       Balloon                  15 F                      Laser
  RIRS                        14/16               UAS                      7.5 F                    Laser                     
  Ozgor et al. \[[@B27]\]     Mini-PCNL           18 or 20                 Amplatz                  17 F                      Laser and ultrasound
  RIRS                        19/23               UAS                      7.5 F                    Laser                     
  Wilhelm et al. \[[@B18]\]   Mini-PCNL           10 and 14                PTFE dilators/Amplatz    13 F                      Laser
  RIRS                        7/8                 UAS                      ---                      Laser                     
  Pan et al. \[[@B22]\]       Mini-PCNL           18                       Amplatz                  14 F                      Laser
  RIRS                        12                  UAS                      Olympus P3 or P5         Laser                     
  Kirac et al. \[[@B24]\]     Mini-PCNL           20                       Amplatz                  15--16.5 F                Pneumatic or ultrasound energy
  RIRS                        9.5/11.5 or 12/14   UAS                      8 or 9.5 F,              Laser                     
  Kumar et al. \[[@B16]\]     Mini-PCNL           18                       gauge needle             15 F                      Pneumatic
  RIRS                        12                  UAS                      8/9.8 F                  Laser                     
  Sabnis et al. \[[@B21]\]    Mini-PCNL           16--19                   22-gauge Skinny Needle   15/18 F and 16.5/19.5 F   Laser
  RIRS                        14                  UAS                      7.5-F Flex X--2          Laser                     
  Kruck et al. \[[@B25]\]     Mini-PCNL           16--18                   Metal                    12 F                      Ultrasound
  RIRS                        ---                 Fascial dilator          Flex-X/Flex-X2           Laser                     
  Hu et al. \[[@B26]\]        mPCNL               16--20                   Fascial dilator          8/9.8 F                   Laser
  RIRS                        12/14               UAS                      Flex-X2                  Laser                     
  Zeng et al. \[[@B19]\]      Mini-PCNL           18                       Fascial dilators         ---                       Laser and pneumatic
  RIRS                        12/14               UAS                      7.5 F                    Laser                     
  Zhang et al. \[[@B23]\]     Mini-PCNL           18--20                   facial dilators          8.6/9.8 F                 Laser and pneumatic
  RIRS                        12/14               UAS                      5.3--8.4 F               Laser                     
  Gu et al. \[[@B15]\]        Mini-PCNL           12/18                    Fascial dilators         8.5/9.8 F                 Laser
  RIRS                        ---                 UAS                      7.4 F                    Laser                     
  Knoll et al. \[[@B20]\]     Mini-PCNL           18                       Amplatz                  14 F                      Laser
  RIRS                        12/14               ---                      ---                      Laser                     

Mini-PCNL = minimally invasive percutaneous nephrolithotomy; RIRS = retrograde intrarenal surgery; UAS = ureteral access sheath placement.

###### 

Clavien-Dindo Classification for surgical complication.

  Surgical complications classification   Description                                                                                                                                                  For example
  --------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------ -----------------------------------------------------------------------------------------------------------------------------------
  Grade I                                 Any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic, and radiological interventions.   Bleeding, pain, fever, vomiting, tachycardia, hyperkalemia, and so forth.
  Grade II                                Requiring pharmacological treatment with drugs other than such allowed for grade I complications.                                                            Minor pelvic/ureter perforation, hypertension requiring nicardipine, urinary tract infection, subcapsular hematoma, and so forth.
  Grade III                               Requiring surgical, endoscopic, or radiological intervention.                                                                                                Embolization, steinstrasse, and so forth.
  Grade IV                                Life-threatening complication (including CNS complications)^‡^ requiring IC/ICU-management                                                                   Shock and so forth.
  Grade V                                 Death of a patient.                                                                                                                                          Death and so forth.

###### 

Sensitivity analysis results.

  Items                Studies                                      Sample size   Tests for heterogeneity   Analysis model   Test for overall effect   RR/WMD 95% CI   Favors                           
  -------------------- -------------------------------------------- ------------- ------------------------- ---------------- ------------------------- --------------- -------- ----------------------- -----------
  Stone-free rate      \[[@B17], [@B27], [@B16], [@B19], [@B15]\]   215/214       51%                       0.09             Fixed                     2.52            0.01     1.92 \[1.16, 3.18\]     Mini-PCNL
  Operative time       \[[@B17], [@B27], [@B16], [@B19], [@B15]\]   215/214       94%                       \<0.00001        Random                    1.06            0.29     7.60 \[−5.32, 20.53\]   RIRS
  Hemoglobin drop      \[[@B17], [@B19]\]                           88/86         0                         0.60             Random                    1.55            0.12     0.21 \[−0.06, 0.47\]    RIRS
  Hospital stay        \[[@B17], [@B27], [@B15]\]                   121/118       94%                       \<0.00001        Random                    1.99            0.05     1.34 \[0.02, 2.67\]     RIRS
  Total complication   \[[@B17], [@B27], [@B16], [@B19]\]           185/185       84%                       0.00003          Random                    0.44            0.66     1.38 \[0.33, 5.84\]     RIRS
  Grade I              \[[@B17], [@B27], [@B16], [@B19]\]           185/185       78%                       0.04             Random                    0.44            0.66     1.35 \[0.35, 5.15\]     RIRS
  Grade II             \[[@B17], [@B27], [@B16], [@B19]\]           185/185       0                         0.65             Random                    0.46            0.64     1.22 \[0.52, 2.86\]     RIRS
  Grade III            \[[@B27], [@B19]\]                           109/109       35%                       0.21             Random                    0.94            0.35     3.36 \[0.27, 41.48\]    RIRS

Mini-PCNL: minimally invasive percutaneous nephrolithotomy; RIRS: retrograde intrarenal surgery; RR: relative risk; WMD: weighted mean difference; CI: confidence interval.

###### 

Efficiency quotient in included studies.

  Study                     EQ for mini-PCNL   EQ for RIRS   *P* value
  ------------------------- ------------------ ------------- -----------
  Pan et al. \[[@B22]\]     0.904              0.523         ---
  Kumar et al. \[[@B16]\]   0.915              0.842         0.01
  Gu et al. \[[@B15]\]      0.830              0.500         ---

EQ = efficiency quotient.

[^1]: Academic Editor: Christian Schwentner
